NOV Inc's stock plummeted 5.05% on Thursday, February 6th, 2025, during the intraday trading session. The drop followed the company's latest annual results, which showed earnings per share of $1.60, modestly exceeding analysts' expectations. However, analysts were underwhelmed by the company's revenue of $8.9 billion, which was largely in line with projections.
Following the results, several analysts lowered their forecasts for NOV's performance in 2025. Analysts at JP Morgan cut their price target on NOV to $36 from $60, citing concerns about the company's ability to grow revenue amid a slowing economic environment. Similarly, FMC Corp analysts slashed their price target to $36 from $60, citing headwinds in the company's core business segments.
Despite the earnings disappointment, NOV Inc maintains an average rating of "overweight" among analysts polled by FactSet, with a mean price target of $18.70. RBC recently raised its price target on NOV to $22 from $21, though it maintained a "sector perform" rating on the stock.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.